Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome.
Rett syndrome (RTT) is a neurodevelopmetal disorder associated with mutations in the methyl-CpG-binding protein 2 (MeCP2) gene. MeCP2-deficient mice recapitulate the neurological degeneration observed in RTT patients. Recent studies indicated a role of not only neurons but also glial cells in neuron...
Main Authors: | Yasunori Okabe, Tomoyuki Takahashi, Chiaki Mitsumasu, Ken-ichiro Kosai, Eiichiro Tanaka, Toyojiro Matsuishi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3332111?pdf=render |
Similar Items
-
MeCP2: The Genetic Driver of Rett Syndrome Epigenetics
by: Katrina V. Good, et al.
Published: (2021-01-01) -
Structural investigation of Rett-inducing MeCP2 mutations
by: Ottavia Spiga, et al.
Published: (2019-03-01) -
The Molecular Functions of MeCP2 in Rett Syndrome Pathology
by: Osman Sharifi, et al.
Published: (2021-04-01) -
MeCP2_e2 partially compensates for lack of MeCP2_e1: A male case of Rett syndrome
by: Ryo Takeguchi, et al.
Published: (2020-02-01) -
Glial Dysfunction in MeCP2 Deficiency Models: Implications for Rett Syndrome
by: Uri Kahanovitch, et al.
Published: (2019-08-01)